SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-19-005517
Filing Date
2019-02-04
Accepted
2019-02-04 16:05:29
Documents
2
Group Members
NOVARTIS AG

Document Format Files

Seq Description Document Type Size
1 SC 13G a19-3919_1sc13g.htm SC 13G 84331
2 EX-99.1 a19-3919_1ex99d1.htm EX-99.1 10521
  Complete submission text file 0001104659-19-005517.txt   96331
Mailing Address 45 WIGGINS AVE. BEDFORD MA 01730
Business Address 45 WIGGINS AVE. BEDFORD MA 01730 857-305-1825
Homology Medicines, Inc. (Subject) CIK: 0001661998 (see all company filings)

IRS No.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90433 | Film No.: 19563711
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 250 MASSACHUSETTS AVENUE CAMBRIDGE MA 02139
Business Address 250 MASSACHUSETTS AVENUE CAMBRIDGE MA 02139 (617) 871-8000
Novartis Institutes for BioMedical Research, Inc. (Filed by) CIK: 0001673852 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G